{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "RPD",
  "name": "Rapid7, Inc.",
  "url": "https://frontierpicks.com/dossiers/RPD/",
  "json_url": "https://frontierpicks.com/dossiers/RPD.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Q2 (2026-08-10) flipped RPD from a pure take-private probe to a cost-out re-rating: ARR still -2.0% YoY at $824M, but EPS beat $0.44 vs $0.35, a 12% headcount cut targets 20% Q4 operating margin, and FY26 EPS guide went to $1.78-1.83. Twelve targets raised 08-11/12 into a $9-15 band; the $13.00 close is already above their $12 median, with the unconfirmed sale process the remaining unpriced leg.",
  "invalidation_trigger": "A weekly close below $11.20 gives back the entire post-Q2 re-rating and puts price back inside the July $10.60–11.20 shelf; secondary break is a public confirmation that the Goldman/JPMorgan process ended with Rapid7 remaining independent.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "semi-foundry-equipment",
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "$600M convertible notes mature March 2027; company states cash plus free cash flow funds repayment. It constrains every capital decision until then.",
    "Restructuring charges of $10–11M land largely in Q3 and Q4 2026, so GAAP results in both quarters carry severance noise versus non-GAAP.",
    "Rapid7 has not publicly confirmed the sale process; all bidder reporting is sourced third-party and the company has declined to comment.",
    "Jana's 6,749,936-share holding is unchanged from the 2026-02-13 13D; headlines calling it a new stake reflect quarterly institutional-holdings reporting.",
    "ARR, guided one quarter ahead, is the disclosure that moves this name more than reported revenue."
  ],
  "body_markdown": "## Current Thesis\nThe leg being bought in Rapid7 changed on 2026-08-10. Through July the only live story was deal odds: Jana Partners' ~10.3% stake, Goldman Sachs and JPMorgan running a process, Advent/Bain/EQT in early talks, and sell-side targets clustered $9–11 around an $11 tape. The Q2 print reset the standalone case. Revenue came in at $210.9M (-1.5% YoY) and ARR at $824.0M (-2.0% YoY) — still shrinking — but non-GAAP EPS was $0.44 against a $0.35 estimate, the board approved a restructuring cutting roughly 12% of headcount for $10–11M of charges, and management raised the FY2026 adjusted EPS guide from $1.52–1.60 to $1.78–1.83 while narrowing revenue to $837–841M. The stated target is 20% non-GAAP operating margin in Q4 2026 against 13.7% in Q2. Twelve desks refreshed targets on 2026-08-11/12 into a $9–15 band. So the narrative now has two legs stacked: a cost-out margin re-rating on a flat top line, and an unresolved take-private that no party has confirmed or killed. The 2026-08-14 close of $13.00 sits above the $12 median of those twelve refreshed targets, +100% over three months and 39.4% below the $21.46 52-week high, with RSI(14) at 69.7.\n\nThe narrative is **accelerating**, dated by the 2026-08-10 print and restructuring announcement and the twelve target revisions on 2026-08-11/12 — a fresh attention cluster after months of a $10.60–11.20 shelf. The qualifier is that the acceleration is already priced through the sell-side median, which is what would flip this toward maturing without any new bad news.\n\n## Bull Case\n- **Margin path is now a number, not a promise.** 20% non-GAAP operating margin targeted for Q4 2026 versus 13.7% in Q2 2026, with the ~12% workforce action substantially complete by end of Q4 (announced 2026-08-10). The FY2026 adjusted EPS guide moved to $1.78–1.83 from $1.52–1.60 against a $1.55 consensus.\n- **Q2 beat on both lines.** Adjusted EPS $0.44 vs $0.35 estimate; revenue $210.883M vs $208.248M estimate (2026-08-10).\n- **Balance sheet covers the 2027 maturity.** Cash, cash equivalents and government securities of $702.6M at 2026-06-30 against $600M of convertible notes due March 2027; management stated current cash plus free cash flow funds the repayment.\n- **Sell-side marked up in bulk.** 2026-08-11/12 raises: Susquehanna $15, Canaccord $14, Stifel $13, UBS $12 (Buy), RBC $12, JPMorgan $12, Barclays $12, Stephens $12, Piper Sandler $12, Baird $10, Scotiabank $10.15, DA Davidson $9. Every one of the twelve was an increase.\n- **The take-private option has not expired.** The Goldman/JPMorgan process reported earlier in 2026 with Advent, Bain and EQT has not been publicly terminated, and a company that just guided to 20% Q4 margins is a cleaner LBO underwrite than one that had not.\n\n## Bear Case\n- **ARR is contracting.** $824.0M in Q2 2026, -2.0% YoY, below the $832M reported for Q1 2026. Detection & response (~55% of ARR) grew ~5% YoY; core platform solutions grew ~1%. Cost cuts do not fix a shrinking recurring base.\n- **Q3 revenue guide is below consensus.** $208–210M against a $210.487M estimate (2026-08-10) — another sequential step down.\n- **Price is through the median target.** $13.00 on 2026-08-14 versus a $12 median of the twelve 2026-08-11/12 targets, with DA Davidson at $9 Underperform and no Buy above $12 except Susquehanna's $15 Neutral and Canaccord's $14 Hold. The bulk of the raised targets are Neutral/Hold/Equal-Weight ratings.\n- **Cutting 12% of staff into a declining ARR base carries execution risk.** Severance of $10–11M is the accounting cost; the operating cost is whatever quota capacity and renewal coverage goes with it.\n- **The deal caveat is unchanged.** Every report on the process has carried the possibility that talks lead nowhere and Rapid7 stays independent. That outcome removes the premium leg with no scheduled warning.\n\n## Setup & Price Structure\nThrough July RPD held a multi-month shelf around $10.60–11.20 while sell-side targets sat at or below it. The 2026-08-10 print broke that shelf upward; the stock traded higher on 2026-08-11 alongside the target raises and closed 2026-08-14 at $13.00. The structure that matters now is the post-print gap zone: the $11.20 area is the top of the old shelf and the origin of the move, so a weekly close back beneath it would erase the entire re-rating rather than trim it. Above, the $14–15 zone is where the two highest refreshed targets sit; between $13.00 and there, the stock is trading on deal expectation rather than published fundamental value.\n\nCrowding and positioning observables, stated as observables: RSI(14) at 69.7 on 2026-08-14, a +100% three-month return, twelve sell-side target revisions inside 48 hours, and a last close above the median of those targets. Against that, the stock is 39.4% below its $21.46 52-week high, so this is a recovery leg off a low rather than a new high being extended. The reported 6,749,936-share Jana holding dated 2026-08-14 matches the 6.76M shares disclosed in the 2026-02-13 13D — inference, not measurement: that reads as a quarterly institutional-holdings restatement of an unchanged position, not fresh accumulation, and it should not be counted as new activist buying.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-16 → 2026-09-15: no scheduled company event identified.** The window contains no confirmed earnings, product or regulatory date. What can arrive undated: any 13D/A from Jana (required within days of a material change in holdings or intent), and any report or 8-K on the outcome of the sale process.\n- **2026-09-30 — fiscal Q3 close.** The quarter in which the bulk of the $10–11M restructuring charge begins to land and the first partial quarter of the cost base that has to produce the 20% Q4 margin.\n- **~2026-11-03 (est.) — Q3 2026 print.** The first check on whether ARR stabilised above $824M and whether the Q3 revenue guide of $208–210M held.\n- **March 2027 — $600M convertible notes mature.** Dated well outside the window but it constrains every capital-structure decision between now and then, including what a sponsor would have to refinance.\n\n## What Would Change Our Mind\nThe structural break is the post-print gap. The entire move from the $10.60–11.20 July shelf to the 2026-08-14 close of $13.00 is attributable to one day of news; a weekly close below $11.20 puts price back inside the shelf that existed when targets clustered $9–11 and says the market has discounted both the margin plan and the deal odds back to where they were. That is the gradeable line.\n\nTwo non-price conditions would do the same work. First, a public confirmation that the process ended with Rapid7 remaining independent — an 8-K, a company statement, or credible reporting that the named sponsors walked — removes the premium leg outright and leaves an ex-growth business with a declining ARR line. Second, a Q3 print (est. ~2026-11-03) showing ARR below $824M with Q4 operating margin guidance short of 20% would break the cost-out leg, at which point neither of the two stories being bought is intact.\n\nThe condition that would raise conviction rather than end it: an announced transaction at a premium to $13.00, or a Q3 report showing ARR flat-to-up sequentially with the margin target reaffirmed.\n\n## Correlation Notes\n- RPD does not track the accelerating Cybersecurity leaders. Q2 ARR -2.0% YoY puts it in the ex-growth cohort with the legacy vulnerability-management names rather than with CRWD/PANW-style compounding; correlation to IGV on ordinary days is weaker than correlation to single-name M&A headlines.\n- The nearest read-across is Tenable, the other public vulnerability-management franchise facing the same core-platform deceleration. A weak VM datapoint there is a read-through to the ~45% of RPD ARR outside detection & response.\n- LBO financing conditions are a live input. A wider high-yield spread or a higher-for-longer rate path compresses what any of Advent, Bain or EQT can bid, which is a rates channel into a stock that otherwise looks idiosyncratic.\n- Small-cap event-driven flow matters more than sector flow here. The 2026-07-21 small-cap roundup framing — buyouts, refinancings and squeezes driving second-half small-cap performance — is the cohort RPD trades with while the process is unresolved.",
  "first_seen": "2026-07-10",
  "last_analyzed": "2026-08-16T16:17:03+00:00",
  "last_synthesized": "2026-08-16",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}